CEO Says Greer Labs Merger Signals Global Aim

From Lenoir News Topic Reports

Stallergenes Greer Logo Image

The recent merger of Lenoir-based Greer Laboratories with France-based Stallergenes is aimed at creating a fully integrated, global biopharmaceutical company, the company’s chairman and chief executive officer says.

During a webcast business update, CEO Fereydoun Firouz said the business model of Stallergenes Greer will allow the company to glow globally in the expanding allergy immunotherapy (AIT) market.

Click here to continuing reading this article.